FIELD: medicine.
SUBSTANCE: method includes introduction of Golimumab at a dose of 50 mg SC 1 times in 4 weeks on the same day to a patient with active disease and ineffectiveness of previous therapy with methotrexate and/or other synthetic DMARDs as a basic anti-inflammatory therapy.
EFFECT: reduction of arterial stiffness in this category of patients due to vasoprotective action of Golimumab both on large elastic-type vessels and small muscle type arteries.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF VASOMOTOR ENDOTHELIAL DYSFUNCTION CORRECTION AND ARTERIAL RIGIDITY IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2018 |
|
RU2696285C1 |
| METHOD FOR CORRECTION OF STRUCTURAL-FUNCTIONAL ARTERIAL BED DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2015 |
|
RU2572709C1 |
| DIAGNOSTIC TECHNIQUE FOR LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2009 |
|
RU2429785C2 |
| METHOD FOR PREDICTING DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2022 |
|
RU2790525C1 |
| PREDICTION PROCEDURE OF SIMVASTATIN BASED CLINICAL EFFECTIVENESS WITH REGARD TO RHEUMATOID ARTHRITIS | 2008 |
|
RU2367430C1 |
| METHOD FOR DETERMINING PSORIATIC ARTHRITIS ACTIVITY | 2020 |
|
RU2746884C1 |
| METHOD FOR DETERMINING HIGH RISK OF CAROTID ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS | 2020 |
|
RU2740246C1 |
| METHOD FOR DIAGNOSING ANEMIA OF CHRONIC DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2021 |
|
RU2783248C1 |
| METHOD OF ESTIMATING SEVERITY OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2013 |
|
RU2536294C1 |
| METHOD FOR DETERMINING INDICATIONS TO BEGINNING OF RECEPTION OF GENETIC ENGINEERING BIOLOGICAL PREPARATIONS WITH INEFFECTIVENESS OF BASIC ANTI-INFLAMMATORY PREPARATIONS IN EARLY FORMS OF PSORIATIC ARTHRITIS | 2020 |
|
RU2731807C1 |
